Imunomodulacijsko zdravljene vnetne črevesne bolezni v pediatriji

Translated title of the contribution: Immunomodulatory therapy in paediatric inflammatory bowel disease

Research output: Contribution to journalArticle

Abstract

Immunomodulatory drugs are indispensable in the treatment of children with both Crohn's disease and ulcerative colitis, especially in maintaining remission. Among them, azathioprine and 6-mercaptopurine are the most effective in this respect and they elicit less adverse reactions compared to other immunomodulatory drugs. A very important benefit of immunomodulatory therapy is that they are steroid-sparing agents, which is especially essential in developing children. Although, due to their slow onset of action, most of these drugs are not appropriate for induction of remission, their early introduction may be helpful in faster tapering of steroids and bridging them to azathioprine or 6-mercaptopurine. In this review the mechanism of action, evidence based therapeutical efficiency and adverse reactions to immunomodulatory drugs will be reviewed.

Original languageUndefined/Unknown
JournalZdravniski Vestnik
Volume82
Issue numberSUPPL.1
Publication statusPublished - 2013

Fingerprint

Immunomodulation
Inflammatory Bowel Diseases
Pediatrics
6-Mercaptopurine
Azathioprine
Pharmaceutical Preparations
Steroids
Remission Induction
Ulcerative Colitis
Crohn Disease
Therapeutics

Keywords

  • Calcineurin inhibitors
  • Immunoregulatory drugs
  • Inflammatory bowel disease
  • Methotrexate
  • Thiopurines

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Imunomodulacijsko zdravljene vnetne črevesne bolezni v pediatriji. / Arató, A.

In: Zdravniski Vestnik, Vol. 82, No. SUPPL.1, 2013.

Research output: Contribution to journalArticle

@article{cb18cc824eef455da35384cd66421e78,
title = "Imunomodulacijsko zdravljene vnetne črevesne bolezni v pediatriji",
abstract = "Immunomodulatory drugs are indispensable in the treatment of children with both Crohn's disease and ulcerative colitis, especially in maintaining remission. Among them, azathioprine and 6-mercaptopurine are the most effective in this respect and they elicit less adverse reactions compared to other immunomodulatory drugs. A very important benefit of immunomodulatory therapy is that they are steroid-sparing agents, which is especially essential in developing children. Although, due to their slow onset of action, most of these drugs are not appropriate for induction of remission, their early introduction may be helpful in faster tapering of steroids and bridging them to azathioprine or 6-mercaptopurine. In this review the mechanism of action, evidence based therapeutical efficiency and adverse reactions to immunomodulatory drugs will be reviewed.",
keywords = "Calcineurin inhibitors, Immunoregulatory drugs, Inflammatory bowel disease, Methotrexate, Thiopurines",
author = "A. Arat{\'o}",
year = "2013",
language = "Undefined/Unknown",
volume = "82",
journal = "Zdravstveni Vestnik",
issn = "1318-0347",
publisher = "Slovene Medical Association",
number = "SUPPL.1",

}

TY - JOUR

T1 - Imunomodulacijsko zdravljene vnetne črevesne bolezni v pediatriji

AU - Arató, A.

PY - 2013

Y1 - 2013

N2 - Immunomodulatory drugs are indispensable in the treatment of children with both Crohn's disease and ulcerative colitis, especially in maintaining remission. Among them, azathioprine and 6-mercaptopurine are the most effective in this respect and they elicit less adverse reactions compared to other immunomodulatory drugs. A very important benefit of immunomodulatory therapy is that they are steroid-sparing agents, which is especially essential in developing children. Although, due to their slow onset of action, most of these drugs are not appropriate for induction of remission, their early introduction may be helpful in faster tapering of steroids and bridging them to azathioprine or 6-mercaptopurine. In this review the mechanism of action, evidence based therapeutical efficiency and adverse reactions to immunomodulatory drugs will be reviewed.

AB - Immunomodulatory drugs are indispensable in the treatment of children with both Crohn's disease and ulcerative colitis, especially in maintaining remission. Among them, azathioprine and 6-mercaptopurine are the most effective in this respect and they elicit less adverse reactions compared to other immunomodulatory drugs. A very important benefit of immunomodulatory therapy is that they are steroid-sparing agents, which is especially essential in developing children. Although, due to their slow onset of action, most of these drugs are not appropriate for induction of remission, their early introduction may be helpful in faster tapering of steroids and bridging them to azathioprine or 6-mercaptopurine. In this review the mechanism of action, evidence based therapeutical efficiency and adverse reactions to immunomodulatory drugs will be reviewed.

KW - Calcineurin inhibitors

KW - Immunoregulatory drugs

KW - Inflammatory bowel disease

KW - Methotrexate

KW - Thiopurines

UR - http://www.scopus.com/inward/record.url?scp=84887471217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887471217&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84887471217

VL - 82

JO - Zdravstveni Vestnik

JF - Zdravstveni Vestnik

SN - 1318-0347

IS - SUPPL.1

ER -